Mayo Clinic Ventures — 2020 Investments
4 investments dated 2020 · listed companies and verified rows first · show all
Elysium develops healthcare products focused on aging research and healthy aging rather than disease treatment.
HealthtechLongevityWellness & FitnessNew York City, US
Leonard Guarente, Ph.D.(Co-founder & Chief Scientist)Dan Alminana(COO, co-founder)inEric Marcotulli(CEO, co-founder)inJason AndersoninLeonard Guarente, PhD(Co-founder & Chief Scientist)David Fialkow(Director)
Co-investorsBreyer CapitalGaingelsOS FundSprint VcThe Venture CollectiveWestern Technology Investment+2 more
South San Francisco biotech engineering commensal gut bacteria into controllable live therapeutics for chronic diseases.
Daly City, US
Weston Whitaker(Executive Officer, Director, Promoter)William DeLoache(Director)Samuel Smits(Director)
BoardElizabeth Stanley(Director)
Co-investorsAlta PartnersCerity Partners VenturesColorcon Ventures5AM VenturesAlexandriaDCVC (Data Collective)+2 more
Progentec develops diagnostic and digital health solutions for autoimmune disease detection and treatment, including biomarker tests and remote monitoring technologies for clinicians and patients.
BiotechDigital HealthMedical DevicesOklahoma City, US
Mohan Purushothaman(CEO)inMohan Purushothaman, Ph.D.(President, Chairman, & CEO; co-founder)Robert Saunders(Director)Sanjiv Sharma(Executive Officer, Director)
Co-investorsPlains VenturesOCA VenturesStanford University
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Predible Health
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.




__Twitter.png)






